Alyeska Investment Group
ISEE

Alyeska Investment Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Alyeska Investment Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200,000
Closed -$4.28M – 573
2022
Q4 		$4.28M Buy
+200,000
New +$4.27M 0.04% 268
2020
Q3 		– Sell
-153,767
Closed -$784K – 618
2020
Q2 		$784K Buy
+153,767
New +$641K 0.01% 413
2013
Q4 		– Sell
-60,000
Closed -$1.78M – 390
2013
Q3 		$1.78M Buy
+60,000
New +$1.7M 0.07% 231

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Alyeska Investment Group's ISEE Position: Q1 2023 in Review

Alyeska Investment Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 200,000 shares — an estimated $4.28M sold.

Alyeska Investment Group first reported a position in ISEE in Q3 2013 and held it in 3 quarters. The position peaked at $4.28M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Alyeska Investment Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 200,000 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $4.28M.
  • Alyeska Investment Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Alyeska Investment Group's IVERIC bio, Inc. Common Stock position peaked at $4.28M in Q4 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.